Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 708
Selected: 0
NCT IDTitle
NCT02054702Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia
NCT01509053Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
NCT02349919Effect of Oral Procaterol on Postinfectious Persistent Cough
NCT01418339Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT02435836A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia
NCT06971731A Study of JNT-517 in Participants With Phenylketonuria (PKU)
NCT07184645A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis
NCT03850509Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation
NCT04109950A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia
NCT03881449DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole
NCT01727726A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
NCT01430494Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease
NCT03287505Aripiprazole IM Depot for Chinese Patients With Schizophrenia
NCT05007821Linezolid Dosing Strategies in Drug-Resistant TB
NCT07455084A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults
NCT00201994Study of Ascending Levels of Tolvaptan in Hyponatremia
NCT01416441Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT00095745A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder
NCT00606281A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
NCT02168920Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
NCT00216723Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder
NCT01565018Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects
NCT01145313Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Disorder
NCT07713758A Trial to Examine if Repinatrabit is Processed Differently in Adults With Reduced Liver or Kidney Function Compared to Adults With Normal Liver and Kidney Function
NCT03538691A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder
NCT02847624Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD
NCT06799520A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)
NCT01649557Multicenter, Open-label, Safety and Tolerability Study
NCT01361607Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
NCT02404532Substudy 'B' of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)
NCT01262651Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer
NCT02160145Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
NCT00549978Safety and Pharmacokinetics of Probucol and Cilostazol
NCT03594123A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
NCT07086313A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
NCT03303079Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine
NCT00666965A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients
NCT03487770Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder
NCT01890694Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia
NCT02722967Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System
NCT00272467Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy
NCT01280721A Study to Investigate the Long-term Safety and Efficacy of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Trial 156-04-251 in Japan]
NCT00279409Treatment of Children With ADHD Who do Not Fully Respond to Stimulants
NCT03240211Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL
NCT01122927Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
NCT03902574Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg
NCT01483183Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
NCT00657176An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors
NCT00036348Study of Aripiprazole in Patients With a History of Bipolar Disorder
NCT02215148Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients